Smith & Nephew experienced periodic market headwinds and share price adjustments following softer-than-expected revenue growth in its U.S. orthopedic divisions, alongside supply chain pressures and integration costs associated with structural transformation programs. In response, executive leadership implemented comprehensive restructuring initiatives, optimization of manufacturing footprints, and targeted portfolio enhancements to restore growth momentum.